Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
Hirsh
J
J
Salzman
E W
EW
Harker
L
L
Fuster
V
V
Dalen
J E
JE
Cairns
J A
JA
Collins
R
R
D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D004176:Dipyridamole / Q000494:pharmacology; D011464:Epoprostenol / Q000096:biosynthesis; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013272:Stomach Diseases / Q000139:chemically induced; D013928:Thromboxane A2 / Q000096:biosynthesis
D010975:Platelet Aggregation Inhibitors; D013928:Thromboxane A2; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin